← back to search

Fude Zhou

King University · US
Area of research
Nephrology · Molecular Biology
Research interest
Research interests include Medicine, Intensive care medicine, Acute kidney injury, Creatinine, Predictive modelling, and Portal hypertension.
h-index
citations
46
works
2
NIH funding
primary concept
email

Recent publications

Development and validation of a real-time prediction model for acute kidney injury in hospitalized patients
Nature Communications 2025cited by 43position: middledoi
Late-onset renal TMA and tubular injury in cobalamin C disease: a report of three cases and literature review
BMC Nephrology 2024cited by 4position: lastdoi
Crescentic Glomerulonephritis and Portal Hypertension with Chronic Q Fever: A Case Report and Comprehensive Literature Review
Infection and Drug Resistance 2024cited by 3position: middledoi
Characteristics of Complement Protein Deposition in Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition
Clinical Journal of the American Society of Nephrology 2023cited by 10position: middledoi
A rare case of membranous nephropathy associated with chronic inflammatory demyelinating polyradiculoneuropathy
Renal Failure 2023cited by 3position: middledoi
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes
Journal of Nephrology 2022cited by 6position: middledoi
Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
Frontiers in Medicine 2021cited by 22position: middledoi
Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review
BMC Nephrology 2021cited by 11position: lastdoi
Case Report: Predominant Tubulointerstitial Lupus Nephritis or the Combination With IgG4-Related Disease?
Frontiers in Medicine 2021cited by 4position: middledoi
Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients
Amyloid 2020cited by 27position: middledoi
Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China
Nephrology 2019cited by 14position: middledoi
Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort
Nephrology Dialysis Transplantation 2017cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ming‐Hui Zhao · Tokyo University of Agriculture and Technology8 papers (2017–2023)Suxia Wang · Peking University5 papers (2020–2024)Xiaojuan Yu · King University5 papers (2019–2023)Zhao Cui · King University3 papers (2017–2021)Yi-Miao Zhang · Ministry of Education of the People's Republic of China2 papers (2017–2021)Rong Xu · Nantong University2 papers (2021–2023)Liqiang Meng · King University2 papers (2017–2021)Xin Wang · King University2 papers (2017–2021)Danyang Li · South China Agricultural University2 papers (2019–2020)Li Yang · The First Affiliated Hospital, Sun Yat-sen University2 papers (2024–2025) · 2 papers (2024–2024)Youlu Zhao · King University2 papers (2021–2025)Ai-bo Qin · King University1 papers (2022–2022)Xiaoyu Jia · Henan Medical University1 papers (2021–2021)Wanyin Hou · King University1 papers (2024–2024) · 1 papers (2021–2021)Sufang Shi · University of Leicester1 papers (2024–2024)Su‐Xia Wang · King University1 papers (2019–2019)J. B. Jiao · Harbin Medical University1 papers (2025–2025)Rong Xu · Lishui City People's Hospital1 papers (2024–2024)